BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Diagnosis
62 results:

  • 1. Body mass trajectory from diagnosis to the end of treatment in a pediatric acute lymphoblastic leukemia cohort.
    Galati PC; Rocha PRS; Gruezo ND; Amato AA
    Sci Rep; 2023 Aug; 13(1):13590. PubMed ID: 37604919
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Analysis of
    Cui M; Li QY; Lu XZ; Chao HY; Cai XH; Liu J; Hua HY; Wu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1019-1025. PubMed ID: 37551471
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cytogenetic Characteristics of de novo Acute Myeloid leukemia in Southern Vietnam.
    Thao LTT; Ha CT; Ha NTT; Beaupha SMC; Nghia H; Tung TT; Son NT; Binh NT; Dung PC; Vu HA; Xinh PT
    Asian Pac J Cancer Prev; 2023 May; 24(5):1789-1795. PubMed ID: 37247302
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders.
    Mikulska M; Testi D; Russo C; Balletto E; Sepulcri C; Bussini L; Dentone C; Magne F; Policarpo S; Campoli C; Miselli F; Cilli A; Ghiggi C; Aquino S; Di Grazia C; Giannella M; Giacobbe DR; Vena A; Raiola AM; Bonifazi F; Zinzani P; Cavo M; Lemoli R; Angelucci E; Viale P; Bassetti M; Bartoletti M
    Br J Haematol; 2023 May; 201(4):628-639. PubMed ID: 36806152
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland.
    Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
    Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Interferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival.
    Abu-Zeinah G; Krichevsky S; Cruz T; Hoberman G; Jaber D; Savage N; Sosner C; Ritchie EK; Scandura JM; Silver RT
    Leukemia; 2021 Sep; 35(9):2592-2601. PubMed ID: 33654206
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Evaluation of Empiric Vancomycin for Fevers During High-dose Cytarabine Administration.
    Hoover A; Zimmerman JAO; Wiese S; Modi A
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e1010-e1014. PubMed ID: 33560084
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia.
    Li B; Brady SW; Ma X; Shen S; Zhang Y; Li Y; Szlachta K; Dong L; Liu Y; Yang F; Wang N; Flasch DA; Myers MA; Mulder HL; Ding L; Liu Y; Tian L; Hagiwara K; Xu K; Zhou X; Sioson E; Wang T; Yang L; Zhao J; Zhang H; Shao Y; Sun H; Sun L; Cai J; Sun HY; Lin TN; Du L; Li H; Rusch M; Edmonson MN; Easton J; Zhu X; Zhang J; Cheng C; Raphael BJ; Tang J; Downing JR; Alexandrov LB; Zhou BS; Pui CH; Yang JJ; Zhang J
    Blood; 2020 Jan; 135(1):41-55. PubMed ID: 31697823
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Positive predictive value of CD200 positivity in the differential diagnosis of chronic lymphocytic leukemia.
    Sorigue M; Magnano L; Miljkovic MD; Nieto-Moragas J; Santos-Gomez M; Villamor N; Junca J; Morales-Indiano C
    Cytometry B Clin Cytom; 2020 Sep; 98(5):441-448. PubMed ID: 31692239
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Epidemiology, utilisation of healthcare resources and outcome of invasive fungal diseases following paediatric allogeneic haematopoietic stem cell transplantation.
    Linke C; Ehlert K; Ahlmann M; Fröhlich B; Mohring D; Burkhardt B; Rössig C; Groll AH
    Mycoses; 2020 Feb; 63(2):172-180. PubMed ID: 31661569
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Outcome after intensive reinduction therapy and allogeneic stem cell transplant in paediatric relapsed acute myeloid leukaemia.
    Karlsson L; Forestier E; Hasle H; Jahnukainen K; Jónsson ÓG; Lausen B; Norén Nyström U; Palle J; Tierens A; Zeller B; Abrahamsson J
    Br J Haematol; 2017 Aug; 178(4):592-602. PubMed ID: 28439893
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL).
    Jain P; Aoki E; Keating M; Wierda WG; O'Brien S; Gonzalez GN; Ferrajoli A; Jain N; Thompson PA; Jabbour E; Kanagal-Shamanna R; Pierce S; Alousi A; Hosing C; Khouri I; Estrov Z; Cortes J; Kantarjian H; Ravandi F; Kadia TM
    Ann Oncol; 2017 Jul; 28(7):1554-1559. PubMed ID: 28379307
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Biopsy first: Lessons learned from Cancer and leukemia Group B (CALGB) 140503.
    Kohman LJ; Gu L; Altorki N; Scalzetti E; Veit LJ; Wallen JM; Wang X
    J Thorac Cardiovasc Surg; 2017 Jun; 153(6):1592-1597. PubMed ID: 28274562
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemia.
    Qin YZ; Wang Y; Xu LP; Zhang XH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Chen Y; Mo XD; Zhao XS; Chang YJ; Liu KY; Huang XJ
    J Hematol Oncol; 2017 Feb; 10(1):44. PubMed ID: 28166825
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Acute myeloid leukemia: a retrospective claims analysis of resource utilization and expenditures for newly diagnosed patients from first-line induction to remission and relapse.
    Irish W; Ryan M; Gache L; Gunnarsson C; Bell T; Shapiro M
    Curr Med Res Opin; 2017 Mar; 33(3):519-527. PubMed ID: 27966377
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.
    ; Fitzmaurice C; Allen C; Barber RM; Barregard L; Bhutta ZA; Brenner H; Dicker DJ; Chimed-Orchir O; Dandona R; Dandona L; Fleming T; Forouzanfar MH; Hancock J; Hay RJ; Hunter-Merrill R; Huynh C; Hosgood HD; Johnson CO; Jonas JB; Khubchandani J; Kumar GA; Kutz M; Lan Q; Larson HJ; Liang X; Lim SS; Lopez AD; MacIntyre MF; Marczak L; Marquez N; Mokdad AH; Pinho C; Pourmalek F; Salomon JA; Sanabria JR; Sandar L; Sartorius B; Schwartz SM; Shackelford KA; Shibuya K; Stanaway J; Steiner C; Sun J; Takahashi K; Vollset SE; Vos T; Wagner JA; Wang H; Westerman R; Zeeb H; Zoeckler L; Abd-Allah F; Ahmed MB; Alabed S; Alam NK; Aldhahri SF; Alem G; Alemayohu MA; Ali R; Al-Raddadi R; Amare A; Amoako Y; Artaman A; Asayesh H; Atnafu N; Awasthi A; Saleem HB; Barac A; Bedi N; Bensenor I; Berhane A; Bernabé E; Betsu B; Binagwaho A; Boneya D; Campos-Nonato I; Castañeda-Orjuela C; Catalá-López F; Chiang P; Chibueze C; Chitheer A; Choi JY; Cowie B; Damtew S; das Neves J; Dey S; Dharmaratne S; Dhillon P; Ding E; Driscoll T; Ekwueme D; Endries AY; Farvid M; Farzadfar F; Fernandes J; Fischer F; G/Hiwot TT; Gebru A; Gopalani S; Hailu A; Horino M; Horita N; Husseini A; Huybrechts I; Inoue M; Islami F; Jakovljevic M; James S; Javanbakht M; Jee SH; Kasaeian A; Kedir MS; Khader YS; Khang YH; Kim D; Leigh J; Linn S; Lunevicius R; El Razek HMA; Malekzadeh R; Malta DC; Marcenes W; Markos D; Melaku YA; Meles KG; Mendoza W; Mengiste DT; Meretoja TJ; Miller TR; Mohammad KA; Mohammadi A; Mohammed S; Moradi-Lakeh M; Nagel G; Nand D; Le Nguyen Q; Nolte S; Ogbo FA; Oladimeji KE; Oren E; Pa M; Park EK; Pereira DM; Plass D; Qorbani M; Radfar A; Rafay A; Rahman M; Rana SM; Søreide K; Satpathy M; Sawhney M; Sepanlou SG; Shaikh MA; She J; Shiue I; Shore HR; Shrime MG; So S; Soneji S; Stathopoulou V; Stroumpoulis K; Sufiyan MB; Sykes BL; Tabarés-Seisdedos R; Tadese F; Tedla BA; Tessema GA; Thakur JS; Tran BX; Ukwaja KN; Uzochukwu BSC; Vlassov VV; Weiderpass E; Wubshet Terefe M; Yebyo HG; Yimam HH; Yonemoto N; Younis MZ; Yu C; Zaidi Z; Zaki MES; Zenebe ZM; Murray CJL; Naghavi M
    JAMA Oncol; 2017 Apr; 3(4):524-548. PubMed ID: 27918777
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.
    Agostinelli C; Gallamini A; Stracqualursi L; Agati P; Tripodo C; Fuligni F; Sista MT; Fanti S; Biggi A; Vitolo U; Rigacci L; Merli F; Patti C; Romano A; Levis A; Trentin L; Stelitano C; Borra A; Piccaluga PP; Hamilton-Dutoit S; Kamper P; Zaucha JM; Małkowski B; Kulikowski W; Tajer J; Subocz E; Rybka J; Steidl C; Broccoli A; Argnani L; Gascoyne RD; d'Amore F; Zinzani PL; Pileri SA
    Lancet Haematol; 2016 Oct; 3(10):e467-e479. PubMed ID: 27692305
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinical significance of microRNAs in chronic and acute human leukemia.
    Yeh CH; Moles R; Nicot C
    Mol Cancer; 2016 May; 15(1):37. PubMed ID: 27179712
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Hospital discharge records as data source to monitor epidemiologic indicators of hematologic malignancies in Abruzzo.
    Vitullo F; Di Biagio K; Murgano A; Di Bartolomeo P
    Tumori; 2016 Jun; 2016(3):258-63. PubMed ID: 26917409
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Molecular response with triple therapy in patients with chronic myeloid leukemia].
    López-Arroyo JL; Rico-Ramos HJ; Portillo-García ML
    Rev Med Inst Mex Seguro Soc; 2014; 52(3):262-5. PubMed ID: 24878083
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.